What is Winder Labs?
Winder Laboratories, LLC operates as a critical node in the pharmaceutical supply chain, maintaining rigorous FDA and DEA approvals. Based in Winder, Georgia, the organization provides specialized analytical services, including high-performance liquid chromatography (HPLC), gas chromatography (GC), and dissolution testing. As a licensed handler of controlled substances across schedules II through V, Winder Labs serves a diverse clientele ranging from retail pharmacies to large-scale wholesale distributors. Their commitment to regulatory compliance and high-precision testing makes them an essential partner for entities operating within the food, drug, and mass-market sectors, ensuring that pharmaceutical products meet stringent safety and quality benchmarks.
How much funding has Winder Labs raised?
Winder Labs has raised a total of $919K across 2 funding rounds:
Debt
$350K
Debt
$569K
Debt (2020): $350K with participation from PPP
Debt (2021): $569K led by PPP
Key Investors in Winder Labs
PPP
Public-Private Partnership
What's next for Winder Labs?
With the recent influx of capital, Winder Labs is positioned to optimize its manufacturing throughput and expand its analytical service offerings. The strategic focus will likely center on enhancing laboratory automation and increasing the capacity for controlled substance processing, which remains a high-barrier-to-entry segment of the market. As the company navigates the complexities of the pharmaceutical landscape, the integration of advanced testing methodologies will be pivotal in maintaining its competitive advantage. Future growth will likely be driven by deepening relationships with national wholesale networks and potentially diversifying its portfolio to include emerging therapeutic categories, thereby cementing its role as a cornerstone of domestic pharmaceutical infrastructure.
See full Winder Labs company page
